“Possibility to start immunization in Germany on the 26th”–
Corona 19 vaccine developed by US pharmaceutical company Pfizer and German Bioentech. /Reuters Yonhap News
–
Reuters reported on the 15th (local time) “The European Medicines Agency (EMA) will make a positive decision on the approval of the use of a novel coronavirus infection (Corona 19) vaccine by US pharmaceutical company Pfizer and German Bioentech on the 23rd.” Reported. If realized, it will be the first COVID-19 vaccine approved by EMA.
EMA recently announced that it will decide whether to approve the Pfizer vaccine, which has been applied for emergency use, by the 29th. According to Reuters, it is decided by approval for use, and the timing of the decision is also accelerated.
Reuters also said, “According to the approval, vaccination may begin on the 26th in Germany.”
EMA is an organization responsible for evaluating the efficacy and safety of drugs including the Corona 19 vaccine in the European Union (EU) and determining whether to approve the use.
